4D Molecular Therapeutics, Inc.

Q2 2023 13F Holders

Symbol
FDMT
CUSIP
35104E100
Type
Equity
Class
COM
Num filings
106
Total reported value, excl. options
$745 M
Manager Report Date Value ($000) Shares Option Type